Quantum Base Holdings plc (AIM: QUBE), the quantum science company focused on creating a new global standard in authentication, has been awarded a £0.7 million non-dilutive grant through the UK Research and Innovation Future Leaders Fellowship programme. The grant supports a four-year research programme led by Dr William Thom, Head of Materials Science, running from 1 November 2026 to 31 October 2030, with an option to extend for a further three years. The funding is expected to recover approximately 70% of the cost of a dedicated research team already within the Group's cost base, reducing net operating costs while expanding innovation activity.

Key Points

  • Quantum Base Holdings plc (AIM: QUBE)
  • UKRI Future Leaders Fellowship Grant of £0.7 million awarded to support the Q-MAT research programme led by Dr William Thom
  • Four-year programme runs from 1 November 2026 to 31 October 2030, with a potential further three-year extension; funding recovers approximately 70% of an existing research team's costs
  • Investors may watch for progress in extending Q-ID® technology across new substrates including glass, metals and polymers, and entry into new commercial markets

UKRI Grant Funds Q-MAT Programme to Advance Quantum Base's Q-ID® Authentication Technology

The funded research programme, formally titled "Next-Generation Quantum Materials for Intrinsic Authentication (Q-MAT)", will focus on developing the next generation of quantum materials that underpin Q-ID®, Quantum Base's patented authentication solution. Q-ID® tags harness randomness at the atomic level to produce authentication markers that the company describes as practically impossible to replicate. The research will be conducted at Quantum Base's Lancaster facility, and the announcement confirms that all intellectual property generated through the programme will be owned by the company, preserving the Group's long-term commercial interest in any resulting innovations.

Non-Dilutive Funding Structure Reduces Net Operating Costs for Quantum Base

A notable feature of the grant, as stated in the announcement, is its non-dilutive nature, meaning existing shareholders face no equity dilution as a result of the funding. The company disclosed that the £0.7 million is expected to recover approximately 70% of the cost of a dedicated research team already included within the Group's cost base. This structure means Quantum Base can maintain or increase its investment in innovation while simultaneously reducing net operating costs — a combination the disclosure suggests may be of interest to investors monitoring the Group's path towards commercial scale.

New Substrates and Market Expansion Drive Strategic Rationale for Q-MAT

Beyond supporting existing Q-ID® applications, the Q-MAT programme is designed to extend the technology across new substrates including glass, metals and polymers. The announcement states that successful development could broaden the addressable market, supporting entry into sectors such as high-tech manufacturing, aerospace components and polymer banknotes. Quantum Base currently serves global brands, governments and consumers, with authentication performed via unmodified smartphone technology. The Group is also separately developing Q-RAND®, a nanoscale quantum random number generator that has reached prototype stage, underscoring the breadth of its scientific pipeline.

Dr William Thom and Lancaster Facility Central to Quantum Base's Fellowship Award

The Future Leaders Fellowship was awarded specifically to Dr William Thom, Head of Materials Science at Quantum Base, recognising what the announcement describes as outstanding potential for research leadership. UKRI's Future Leaders Fellowships are described as among the UK's most competitive research programmes, administered through Innovate UK, the UK's national innovation agency. The award is based at Quantum Base's Lancaster facility, reinforcing the site's role as the Group's primary research hub. The company's CEO, Tom Taylor, commented in the announcement that securing the grant reflects the strength of the company's science and the commercial potential of its technology.